NCT00040235View on ClinicalTrials.gov

Magnesium Effects in Apheresis

PHASE3CompletedINTERVENTIONAL

Enrollment

52

Participants

Timeline

Start Date

June 30, 2002

Study Completion Date

February 29, 2004

Conditions

Healthy

Interventions

PROCEDURE

magnesium

Trial Locations (1)

20892

Warren G. Magnuson Clinical Center (CC), Bethesda

All Listed Sponsors

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00040235 - Magnesium Effects in Apheresis | Biotech Hunter | Biotech Hunter